A 4-year evaluation of blood pressure management in Trinidad and Tobago

Size: px
Start display at page:

Download "A 4-year evaluation of blood pressure management in Trinidad and Tobago"

Transcription

1 Journal of Human Hypertension (1999) 13, Stockton Press. All rights reserved /99 $ ORIGINAL ARTICLE A 4-year evaluation of blood pressure management in Trinidad and Tobago D Mahabir 1 and MC Gulliford 2 1 Nutrition and Metabolism Division, Ministry of Health, Trinidad and Tobago; 2 Department of Public Health Sciences, King s College, London SE1 3QD, UK This paper reports a 4-year evaluation of government primary care services in Trinidad and Tobago. The sample included 16 primary care health centres in Trinidad and Tobago with cross-sectional surveys of adult attenders in 1994 and Data were obtained from clinic records including details of processes of care, drug utilisation and blood pressure (BP) control. Intervention following the initial survey was by means of reports to the Ministry of Health and annual training workshops for medical officers. Data were analysed for 1759 adult attenders at study clinics (981 in 1994 and 778 in 1998). Most attenders had blood pressure (96% in 1994 and 98% in 1998). Among 1176 subjects with hypertension (BP 160/95 mm Hg or treated with drugs) the proportion with dietary advice ever increased from 139/662 (21%) in 1994 to 185/514 (36%) in 1998, and recording of exercise advice increased from 36 (5%) in 1994 to 99 (19%) in Among subjects treated with drugs, use of Brinerdin decreased from 191/625 (31%) in 1994 to 29/486 (6%) in 1998, while use of diuretics, beta-blockers, calcium antagonists and ACE inhibitors increased. The proportion of patients with blood pressure adequately controlled ( 160/95 mm Hg) was 338 (51%) in 1994 and 297 (58%) in 1998 (odds ratio 1.39, 95% confidence interval 0.96 to 2.00). An audit study used to inform health care policy, staff training and clinical practice may contribute to improving processes of hypertension management in a middleincome country like Trinidad and Tobago. Keywords: medical audit; health care delivery; quality of health care; West Indies Introduction Hypertension is judged to be a serious health problem in the Caribbean region whether measured in terms of the high prevalence of the condition, 1,2 or the mortality 3,4 and health service use 5 which result from its complications. Evidence from randomised controlled trials shows that treatment of hypertension can reduce the risk of stroke by 40% and coronary heart disease by approximately 15% 6 but poor quality of care may often diminish the effectiveness of blood pressure management. 7 Our aim in the present study was to evaluate the quality of blood pressure management in government primary care health centres in Trinidad and Tobago. This twin-island republic has a predominantly bi-ethnic population, with some 40% being of African descent and 40% of Indian descent, with most of the remainder being of mixed ethnicity. The per capita GDP of Trinidad and Tobago was US$3600 in with a median monthly income in men of about 150 per month. 9 Government health expenditure was estimated to be 2.8% of GDP in 1990 and this accounted for 63% of total health expenditure. 10 Government primary care services in Trinidad Correspondence: MC Gulliford, Department of Public Health Sciences, King s College London, Capital House, 42 Weston St, London SE1 3QD, UK Received 12 February 1999; revised 25 March 1999; accepted 26 March 1999 and Tobago are provided through a network of approximately 100 health centres which are distributed throughout the country. Health centres do not maintain a register of the local population, instead subjects attend by self-referral. Most health centres run clinic sessions for unselected adult attenders but, because of the importance of diabetes and hypertension in this community, many health centres run specially organised chronic disease clinics for clients with these conditions. In a recently reported survey of medical practitioners views on hypertension management, limited availability of drugs was one of the main concerns of doctors working in the public sector. 11 In 1994 we evaluated blood pressure management in public and private primary care settings in Barbados, Jamaica and Trinidad and Tobago and reported our findings in abstract form In government primary care health centres in Trinidad and Tobago, most adult attenders had their blood pressure, many patients with hypertension were treated, but few hypertensive patients had their blood pressure satisfactorily controlled. 13 There was widespread use of pharmaceutical preparations which did not conform with recommendations, especially Brinerdin (a fixed dose combination of clopamide, reserpine and dihydroergocristine) while advice on non-pharmacological measures was neglected. We intervened by reporting our findings directly to the Ministry of Health in Trinidad and Tobago

2 456 and we made presentations at national and regional meetings of scientific and professional bodies. The survey findings were also reported to medical officers in government primary care services in the setting of annual training workshops at which draft guidelines were discussed. This process led to the drafting of new management guidelines at a workshop held in Port of Spain in 1996 and these were formally published early in Our aim in the present study was to determine whether intervention by means of audit, linked with training, resulted in changes in the management of high blood pressure in government primary care health centres in Trinidad and Tobago between 1994 and Subjects and methods Study design and selection of subjects The design was a single group before and after study. Studies with follow-up may be carried out using either cross-sectional or cohort sampling. Cross-sectional sampling was preferred in the present study, both on grounds of administrative convenience and because this approach was more likely to provide a representative sample of clinic attenders at each measurement occasion. 16,17 We report data obtained from 16 health centres which were surveyed on both measurement occasions. The health centres were nominated by County Medical Officers of Health and were located in each of the administrative counties of Trinidad and Tobago. Within each health centre we carried out a census of attenders over a defined time period at the clinic sessions designated for adult attenders. We listed all adult attenders who were aged 30 years and who were neither diabetic nor pregnant. In 1994 the census period was for 4 weeks while in 1998 it was for 3 weeks. Data collection We abstracted data from the subjects clinical records excluding data from the index visit. The data abstracted included: the date of the first clinic visit; records of weight, height, urinalysis, and records of blood glucose, urea and creatinine. We also noted the first and the most recent blood pressure recordings, details of current drug treatment, and whether advice on diet or exercise had ever been. In 1994 data were abstracted by MG and a research nurse, while in 1998 the data were abstracted by staff from the Nutrition Division of the Ministry of Health. Analysis We analysed data using two definitions of hypertension. The WHO definition of hypertension 18 is of blood pressures 160/95 mm Hg, while the US Joint National Committee 19 gives a definition of 140/90 mm Hg. Subjects were also considered to be hypertensive if they were taking antihypertensive drugs including thiazide diuretics, beta-blockers, calcium channel antagonists, angiotensin-converting enzyme inhibitors, methyldopa, reserpine, vasodilators, alpha-blockers, adrenergic neuron inhibiting drugs, Brinerdin or other antihypertensive drugs. In order to test for the effect of the survey year while allowing for correlation of responses within health centres, we used the method of Generalised Estimating Equations (GEEs) implemented in the package Stata. 20 The GEE method provides a computationally intensive approach to the estimation of regression models for clustered data. In the present data, the GEE method was used because individual patient values were clustered within health centres. This approach corrects for the correlation of responses within health centres and leads to more conservative estimates than would be obtained with standard individual level analyses. Where appropriate analyses were adjusted for age (by 10-year age group), sex, and duration of follow-up (by quartile). Results Data were analysed for 981 cases in 1994 and 778 in The retrieval rate for eligible case notes was approximately 92% in 1994 and 91% in Twothirds of the subjects were women with a mean age of approximately 60 years. The duration of followup at the health centre was longer in 1998 than in 1994 but there were no differences in mean systolic or diastolic blood pressure between the 2 years (Table 1). Most patients attending the health centres had blood pressures at some time: 945 (96%) in 1994 and 763 (98%) in The blood pressure Table 1 Case mix and process of care variables. Figures are frequencies (per cent of column total) except where stated 1994 (981) 1998 (778) P value Case-mix Female 677 (69) 533 (69) Age (years) a 61 (14) 60 (14) Duration of follow-up 6.5 (4.1) 8.0 (5.2) (years) a Systolic blood pressure 139 (24) 137 (22) (mm Hg) a Diastolic blood pressure 87 (15) 86 (13) (mm Hg) a Process of care BP ever 945 (96) 763 (98) BP in last (86) 695 (89) Weight in last 336 (34) 400 (51) Height ever 11 (1) 76 (10) Urine glucose in last (23) 229 (29) Urine protein in last (22) 153 (20) Smoking habit ever 82 (8) 59 (8) Alcohol use ever 76 (8) 46 (6) Diet advice ever 150 (15) 223 (29) Exercise advice ever 37 (4) 117 (15) a Figures are mean (s.d.).

3 was within the last 12 for 848 (86%) in 1994 and 695 (89%) in 1998 with no significant difference between the 2 years (Table 1). However, the recording of body weight increased from 336 (34%) in 1994 to 400 (51%) in 1998 and more patients had their height at some time, although the proportion was small 76 (10%) in Use of urinalysis did not change significantly between 1994 and There was a significant increase in the proportion of all subjects with advice on diet or exercise in their notes between 1994 and 1998 (Table 1). Among those subjects who were treated with antihypertensive drugs, there were substantial changes in patterns of drug utilisation between 1994 and 1998 (Table 2). In 1994, 191 (31%) were treated with Brinerdin but by 1998 this proportion had fallen to 29 (6%). In 1998 more use was made of thiazide and potassium sparing diuretic combinations, particularly Dyazide (triamterene with hydrochlorothiazide) increasing from 47 (8%) to 105 (22%). There was also an increase in the use of betablockers from 103 (16%) in 1994 to 132 (27%) in 1998, and ACE inhibitors from 52 (8%) in 1994 to 98 (20%) in There was also a slight increase in the use of calcium channel antagonists from 28 (4%) in 1994 to 39 (8%) in After excluding 51 cases with no blood pressure records available, the proportion of cases with hypertension was estimated according to two definitions (Table 3). The proportion with hypertension was 1176/1708 (69%) according to the WHO definition and 1337/1708 (78%) according to the more stringent definition of 140/90 mm Hg (Table 3). A high proportion of subjects with hypertension were treated with antihypertensive drugs: 1111/1176 (94%) according to WHO definition and 1111/1337 (83%) according to the JNC-VI definition with no differences between years. Among subjects with hypertension according to the WHO definition, 338 (51%) had adequate control (BP 160/95 mm Hg) in 1994 and 297 (58%) in 1998 (Table 3). According to the criterion of 140/90 mm Hg, 110 (15%) of subjects had adequate blood pressure control in 1994 and 76 (13%) in Differences between study years were not significant even after adjusting for age, sex and the duration of follow-up at the clinic Table 2 Drug utilisation in subjects prescribed antihypertensive drugs. Figures are frequencies (per cent of column total). Note categories are not mutually exclusive 1994 (625) 1998 (486) P value Brinerdin 191 (31) 29 (6) Thiazide diuretics 66 (11) 97 (20) Thiazide and potassium 47 (8) 105 (22) sparing diuretic combination Beta-blockers 103 (16) 132 (27) ACE inhibitor 52 (8) 98 (20) Calcium antagonist 28 (4) 39 (8) Methyl dopa 206 (33) 162 (33) Other antihypertensive 21 (3) 7 (1) drugs Note: six cases with no BP records excluded. Table 3 Indicators of blood pressure control, in subjects with blood pressure recordings 1994 (945) 1998 (763) P value a BP 160/95 mm Hg or 662 (70) 514 (67) on drugs on antihypertensive 625 (94) 486 (95) drugs b received diet advice b 139 (21) 185 (36) received exercise 36 (5) 99 (19) advice b BP controlled 338 (51) 297 (58) ( 160/95) b BP 140/90 mm Hg or 744 (79) 593 (78) on drugs on antihypertensive 625 (84) 486 (82) drugs c diet advice c 143 (19) 194 (33) exercise advice 36 (5) 105 (18) c BP controlled 110 (15) 76 (13) ( 140/90) c a Adjusted for age, sex and duration of follow-up. b Per cent of cases with BP 160/95 or on drugs. c Per cent of cases with BP 140/90 or on drugs. (Table 3). The adjusted relative odds of blood pressure being controlled (WHO definition) in 1998 compared with 1994 were 1.39 (95% confidence interval 0.96 to 2.00). Discussion Background There is little information available concerning the management of hypertension in middle- and lowincome countries in spite of an increasing awareness of the importance of cardiovascular diseases in association with epidemiological transition. 21 Some health policy analysts have argued that hypertension management should receive a low priority for investment in middle and low income countries 22 but few studies have provided objective data concerning the cost-effectiveness of hypertension treatment in these settings. 23 Many studies have considered variations in hypertension prevalence, 24 but few studies have examined the problems of health care delivery. Selection of appropriate drugs is of great importance because of wide variations in cost. For example, in Mexico in year s supply of enalapril cost 40 times as much as 1 year s supply of hydrochlorothiazide. 25 Quality of care issues are also particularly important in middle and low income countries because trained staff may be few in number and difficult to retain, supplies of pharmaceuticals may be limited, and cultural differences between patients and health care staff may be substantial. Poor quality care tends to reduce the effectiveness of intervention without reducing costs. Relevance of main findings Our data may provide relevant information to those concerned with hypertension control in middle- and low-income countries. First, this report shows that 457

4 458 periodic national surveys of the primary care management of hypertension can be carried out quite efficiently in a small, middle-income country. Secondly, the results document some of the current achievements in the government primary care setting, including the high proportion of attenders in whom the blood pressure is measured, and the high proportion of patients requiring treatment who receive it. Thirdly, our data show that an audit used to inform policy and practice, linked with educational activities, may bring about large changes in drug utilisation and some changes in processes of care over a relatively short time period. Finally, the results document some of the problems that remain, in particular the low rates of control in those treated for hypertension. The changes in drug utilisation which we observed were likely to be the result of changes in drug procurement which is managed at national level. The use of Brinerdin was almost eliminated during this time and there was an increase in the use of diuretics and beta-blockers. However, the increased use of ACE inhibitors and calcium antagonists may give cause for concern because of the high cost of these agents. We also documented changes in processes of care with an increase in the recording of weight and height, and greater documentation of advice on diet and exercise. Rates of hypertension control were relatively low. In their population-based study in Barbados, St Lucia and Jamaica, Freeman et al 26 found that control of blood pressure (using the criterion 160/95 mm Hg) was achieved in 58% in Barbados, 55% in Jamaica and 33% in St Lucia. Similar results have been reported from high-income countries. 19 However, because of the high prevalence of hypertension it is clear that government primary care services will be contributing to a reduction in the population attributable risk by detecting the condition and achieving control in significant proportion. It is not surprising that improved rates of control were not detected in this study. Even randomised controlled trials show small changes in diastolic pressure of approximately 5 mm Hg. In our clinic settings blood pressures are often measured to the nearest 10 mm Hg, making detection of small changes unlikely. Limitations of study Our study included data from a large number of cases, obtained from a large number of health centres. We used standard methods to collect data but we only collected data that were in case notes. Thus we studied the care that was and not the care that was delivered. In a single group before and after study, the effect of intervention will be confounded by the effect of history and a range of external influences may have contributed to the changes which we observed. 27 These include, for example, health sector reforms, pharmaceutical company promotions or changes in staffing. In a pilot study we found that it was difficult to investigate the quality of diagnosis in hypertension. In Trinidad and Tobago, there are both public and private primary care providers and doctor shopping is common. As a result the current place of treatment is often different from the one where a diagnosis of hypertension was made. Conclusion Our data show that an audit study used to inform health care policy, staff training and clinical practice may contribute to improving standards of hypertension management in a middle-income country like Trinidad and Tobago. In common with the experience of high-income countries, 28,29 the changes in quality of care which we documented were of modest size and the data illustrate some of the problems which remain. Acknowledgements The authors thank the Chief Medical Officer of Trinidad and Tobago for permission to report this work. We also thank the staff of the Nutrition Division, the PMO(CS), the staff of the community services and the Commonwealth Caribbean Medical Research Council for assistance. The 1994 survey was supported by a grant from the UK Overseas Development Administration. References 1 Miller GJ et al. Adult male all cause, cardiovascular and cerebrovascular mortality in relation to ethnic group, systolic blood pressure and blood glucose concentration in Trinidad, West Indies. Int J Epidemiol 1988; 17: INTERSALT Cooperative study group. Appendix tables. Centre-specific results by age and sex. J Hum Hypertens 1989; 3: Pan American Health Organisation. Health conditions in the Americas. Volume edition. Washington DC: PAHO/WHO, Gulliford MC. Epidemiological transition in Trinidad and Tobago, West Indies 1953 to Int J Epidemiol 1996; 25: D Mahabir, L Bickram, MC Gulliford. Stroke in Trinidad and Tobago: burden of illness and risk factors. Pan Am J Public Health 1998; 4: Collins R et al. Blood pressure stroke and coronary artery disease. Part 2, short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: Strasser T, Wilhelmsen L. Assessing hypertension control and management. WHO Regional Publications, European Series number 47. World Health Organisation: Geneva, World Development Report. Investing in Health. Oxford University Press: Oxford, Republic of Trinidad and Tobago. Office of the Prime Minister. Central Statistical Office. Annual Statistical Digest 1994/5. Number 41. Central Statistical Office: Port of Spain, Murray CJL, Lopez AD. Global comparative assessments in the health sector. Disease burden, expenditures and intervention packages. World Health Organisation: Geneva, Mahabir D, Gulliford MC. Medical practitioners views on the management of hypertension in Trinidad and Tobago. West Indian Med J 1997; 46: Alert CV, Fraser HS, Taylor J. Quality of blood press-

5 ure monitoring and control in primary care in Barbados. West Indian Med J 1996; 45 (Suppl 2): 24 (abstract). 13 Mahabir D, Bickram L, Picou D, Gulliford MC. Quality of blood pressure monitoring and control in primary care in Trinidad and Tobago. West Indian Med J 1995; 44 (Suppl 2): 15 (abstract). 14 R Wilks et al. Quality of care of hypertension in three clinical settings in Jamaica. West Indian Med J 1998; 47 (Suppl 2): 18 (abstract). 15 Commonwealth Caribbean Medical Research Council. Managing hypertension in primary care in the Caribbean. CCMRC: Port of Spain, Diehr P et al. Optimal survey design for community intervention evaluations: cohort or cross-sectional? J Clin Epidemiol 1995; 48: Feldman HA, McKinlay SM. Cohort versus cross-sectional design in large field trials: precision, sample size and a unifying model. Statist Med 1994; 13: World Health Organisation. Hypertension control. Report of a WHO Expert Committee. Number 862. WHO: Geneva, The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: Stata Statistical Software. Release 5. Volume 3. College Station, Stata Press: Texas, 1997, pp Beevers DG, Prince JS. Some recent advances in noncommunicable diseases in the tropics 1. Hypertension an emerging problem in tropical countries. Trans Roy Soc Trop Med Hygiene 1991; 85: Pearson TA, Jamison DT, Trejo-Gutierrez J. Cardiovascular disease. In: Jamison DT, Mosley WH, Measham AR, Bobadilla JL (eds). Disease control priorities in Developing Countries. Oxford University Press: Oxford, Cooper RS et al. Hypertension treatment and control in sub-saharan Africa: the epidemiological basis for policy. BMJ 1998; 316: Cooper RS et al. The prevalence of hypertension in seven populations of West African origin. Am J Public Health 1997; 87: Calvo-Vargas CG et al. Changes in the costs of antihypertensive medications in a developing country: a study in Mexico comparing 1990 and Am J Hypertens 1998; 11: Freeman V et al. A comparative study of hypertension prevalence, awareness, treatment and control rates in St Lucia, Jamaica and Barbados. J Hypertens 1996; 14: Cook TD, Campbell DT. Quasi-experimentation. Design and analysis issues for field settings. Rand McNally College Publishing Company: Chicago, Grimshaw JM. Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995; 153:

Appendix: Description of the DIETRON model

Appendix: Description of the DIETRON model Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough

More information

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital

Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI

More information

Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613

Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613 Epidemiology of Hypertension 陈 奕 希 3120000591 李 禾 园 3120000050 王 卓 3120000613 1 Definition Hypertension is a chronic medical condition in which the blood pressure in the arteries is elevated. 2 Primary

More information

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8)

Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Management of High Blood Pressure in Adults Based on the Report from the Panel Members Appointed to the Eighth Joint National Committee (JNC8) Adapted by Capital Health Plan Approved by Quality Improvement

More information

HYPERTENSION MANAGEMENT AND SURVEILLANCE AT PRIMARY CARE LEVEL: A SITUATIONAL ANALYSIS IN THE LIMPOPO PROVINCE

HYPERTENSION MANAGEMENT AND SURVEILLANCE AT PRIMARY CARE LEVEL: A SITUATIONAL ANALYSIS IN THE LIMPOPO PROVINCE HYPERTENSION MANAGEMENT AND SURVEILLANCE AT PRIMARY CARE LEVEL: A SITUATIONAL ANALYSIS IN THE LIMPOPO PROVINCE by Dorothy Sekokotla Krisela Steyn Debbie Bradshaw Nolwazi Mbananga Burden of Disease Research

More information

How To Know If You Have Microalbuminuria

How To Know If You Have Microalbuminuria 3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate

More information

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE

ADULT HYPERTENSION PROTOCOL STANFORD COORDINATED CARE I. PURPOSE To establish guidelines for the monitoring of antihypertensive therapy in adult patients and to define the roles and responsibilities of the collaborating clinical pharmacist and pharmacy resident.

More information

Case Study 6: Management of Hypertension

Case Study 6: Management of Hypertension Case Study 6: Management of Hypertension 2000 Scenario Mr Ellis is a fit 61-year-old, semi-retired market gardener. He is a moderate (10/day) smoker with minimal alcohol intake and there are no other cardiovascular

More information

Can Common Blood Pressure Medications Cause Diabetes?

Can Common Blood Pressure Medications Cause Diabetes? Can Common Blood Pressure Medications Cause Diabetes? By Nieske Zabriskie, ND High blood pressure, or hypertension, is a major risk factor for cardiovascular disease. In the United States, approximately

More information

Drug Treatment in Type 2 Diabetes with Hypertension

Drug Treatment in Type 2 Diabetes with Hypertension Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk

More information

Absolute cardiovascular disease risk assessment

Absolute cardiovascular disease risk assessment Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk

More information

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine

Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine Chronic diseases in low and middle income countries: more research or more action? Shah Ebrahim London School of Hygiene & Tropical Medicine More action needed Overview Growing burden of chronic diseases

More information

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD

DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE DRUGS IN DIABETIC PATIENTS WITH CKD WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Elhami et al. SJIF Impact Factor 5.210 Volume 4, Issue 11, 1159-1166 Research Article ISSN 2278 4357 DRUG UTILIZATION EVALUATION OF ANTIHYPERTENSIVE

More information

Hypertension and Diabetes

Hypertension and Diabetes Hypertension and Diabetes C.W. Spellman, D.O., Ph.D., FACOI Professor & Associate Dean Research Dir. Center Diabetes & Metabolic Disorders Texas Tech University Health Science Center Midland-Odessa, Texas

More information

Treatment of Hypertension: JNC 8 and More

Treatment of Hypertension: JNC 8 and More PL Detail-Document #300201 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER February 2014 Treatment of

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Obesity and hypertension among collegeeducated black women in the United States

Obesity and hypertension among collegeeducated black women in the United States Journal of Human Hypertension (1999) 13, 237 241 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE Obesity and hypertension among collegeeducated

More information

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins Type 2 Diabetes Type 2 diabetes is the most common form of diabetes, accounting for 90 95% of cases. 1 Charts 1 and 2 reflect the effect of increasing prevalence on prescribing and costs of products used

More information

61 st ANNUAL CARPHA HEALTH RESEARCH CONFERENCE. June 23 25, 2016 Turks and Caicos Islands CALL FOR PAPERS

61 st ANNUAL CARPHA HEALTH RESEARCH CONFERENCE. June 23 25, 2016 Turks and Caicos Islands CALL FOR PAPERS 61 st ANNUAL CARPHA HEALTH RESEARCH CONFERENCE June 23 25, 2016 Turks and Caicos Islands CALL FOR PAPERS DEADLINE FOR RECEIPT OF PAPERS DECEMBER 1ST, 2015 CALL FOR PAPERS The 61 st Annual CARPHA Health

More information

Understanding Diseases and Treatments with Canadian Real-world Evidence

Understanding Diseases and Treatments with Canadian Real-world Evidence Understanding Diseases and Treatments with Canadian Real-world Evidence Real-World Evidence for Successful Market Access WHITEPAPER REAL-WORLD EVIDENCE Generating real-world evidence requires the right

More information

CDS Starter Kit: Diabetes f ollow-up care

CDS Starter Kit: Diabetes f ollow-up care CDS Starter Kit: Diabetes f ollow-up care Introduction The delivery of high-quality diabetes care is a complex process that requires a provider to consider many pieces of patient information and treatment

More information

Guide to Biostatistics

Guide to Biostatistics MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

COUNTRY PROFILES ON NONCOMMUNICABLE DISEASES

COUNTRY PROFILES ON NONCOMMUNICABLE DISEASES COUNTRY PROFILES ON NONCOMMUNICABLE DISEASES COUNTRY PROFILES ON NONCOMMUNICABLE DISEASES The Pan American Health Organization welcomes requests for permission to reproduce or translate its publications,

More information

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP

More information

High Blood Pressure and Your Kidneys

High Blood Pressure and Your Kidneys High Blood Pressure and Your Kidneys About 65 million Americans have high blood pressure, but as many as one third or three in 10 don't even know it. There are usually no signs or symptoms that your blood

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes

British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes British Columbia Pharmacy Association (BCPhA) Clinical Service Proposal Self-Monitoring of Blood Glucose in Type 2 Diabetes Introduction Self-monitoring of blood glucose (SMBG) is in widespread use among

More information

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE

AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE AVAILABILITY AND ACCESSIBILITY OF CARDIAC REHABILITATION SERVICES IN LOW- AND MIDDLE-INCOME COUNTRIES QUESTIONNAIRE To be completed by Staff Cardiologists at an adult cardiac institute/department. INSTRUCTIONS:

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

Coronary Heart Disease (CHD) Brief

Coronary Heart Disease (CHD) Brief Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs

More information

HIGH BLOOD PRESSURE AND YOUR KIDNEYS

HIGH BLOOD PRESSURE AND YOUR KIDNEYS HIGH BLOOD PRESSURE AND YOUR KIDNEYS www.kidney.org About the Information in this Booklet Did you know that the National Kidney (NKF) Foundation offers guidelines and commentaries that help your healthcare

More information

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s)

UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s) UNIVERSITY OF BIRMINGHAM AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Health economic report on piloted indicator(s) Pilot QOF indicator: The percentage of patients 79

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

Jill Malcolm, Karen Moir

Jill Malcolm, Karen Moir Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are

More information

HYPERTENSION ASSOCIATED WITH RENAL DISEASES

HYPERTENSION ASSOCIATED WITH RENAL DISEASES RENAL DISEASE v Patients with renal insufficiency should be encouraged to reduce dietary salt and protein intake. v Target blood pressure is less than 135-130/85 mmhg. If patients have urinary protein

More information

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)

NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN) NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England

More information

High Blood Pressure (Essential Hypertension)

High Blood Pressure (Essential Hypertension) Sacramento Heart & Vascular Medical Associates February 18, 2012 500 University Ave. Sacramento, CA 95825 Page 1 916-830-2000 Fax: 916-830-2001 What is essential hypertension? Blood pressure is the force

More information

Papers. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Abstract. Introduction.

Papers. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. Abstract. Introduction. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials M R Law, N J Wald, J K Morris, R E Jordan Abstract Objective To determine the average reduction

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

Improving cardiometabolic health in Major Mental Illness

Improving cardiometabolic health in Major Mental Illness Improving cardiometabolic health in Major Mental Illness Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Metabolic

More information

Getting the most from blood pressure medicines

Getting the most from blood pressure medicines P R E S S U R E P O I N T S S E R I E S : NO. 4 Getting the most from blood pressure medicines B L O O D P R E S S U R E A S S O C I AT I O N Pressure Points series Pressure Points is a series of booklets

More information

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4

High Blood Pressure and Chronic Kidney Disease. For People With CKD Stages 1 4 High Blood Pressure and Chronic Kidney Disease For People With CKD Stages 1 4 National Kidney Foundation s Kidney Disease Outcomes Quality Initiative (NKF-KDOQI ) The National Kidney Foundation s Kidney

More information

Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy

Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods

More information

Hypertension Guidelines

Hypertension Guidelines Overview Hypertension Guidelines Aim to reduce Blood Pressure to 140/90 or less (140/80 for diabetics), adding drugs as needed until further treatment is inappropriate or declined. N.B. patients do not

More information

ECONOMIC COSTS OF PHYSICAL INACTIVITY

ECONOMIC COSTS OF PHYSICAL INACTIVITY ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of

More information

Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative

Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative Cardiovascular risk assessment: Audit findings from a nurse clinic a quality improvement initiative Sarah Waldron RN, PG Dip (Adv Ng); Margaret Horsburgh RN, EdD, MA (Hons), Dip Ed, FCNA(NZ) School of

More information

Risk Factors for Alcoholism among Taiwanese Aborigines

Risk Factors for Alcoholism among Taiwanese Aborigines Risk Factors for Alcoholism among Taiwanese Aborigines Introduction Like most mental disorders, Alcoholism is a complex disease involving naturenurture interplay (1). The influence from the bio-psycho-social

More information

Social Care and Obesity

Social Care and Obesity Social Care and Obesity A discussion paper Health, adult social care and ageing Introduction The number of obese people in England has been rising steadily for the best part of 20 years. Today one in four

More information

How to literature search

How to literature search How to literature search Evidence based practice the learning cycle Our ultimate aim is to help you, as a health professional, to make good clinical decisions. This will enable you to give the best possible

More information

Short Term Effects of Coconut Water and Cocoa on Blood Pressure

Short Term Effects of Coconut Water and Cocoa on Blood Pressure Short Term Effects of Coconut Water and Cocoa on Blood Pressure T. Alleyne; A. Alleyne; D. Arrindell; N. Balleram; D. Cozier; R. Haywood; C. Humphrey; L. Pran; K. Rampersad; D. Reyes; S. Bahall; R. Holder;

More information

Hypertension Management in Hypertensive Adults with Diabetes in Primary Care setting

Hypertension Management in Hypertensive Adults with Diabetes in Primary Care setting Hypertension Management in Hypertensive Adults with Diabetes in Primary Care setting Pratik P. Rane, MBA; Archita Bhansali; Ruta Sawant; Dr. Rajender R. Aparasu, MPharm, PhD, FAPhA. Introduction: Hypertension

More information

4. Does your PCT provide structured education programmes for people with type 2 diabetes?

4. Does your PCT provide structured education programmes for people with type 2 diabetes? PCT Prescribing Report Drugs used in Type 2 Diabetes Discussion Points 1. Does your PCT have a strategy for prevention of type 2 diabetes? Does your PCT provide the sort of intensive multifactorial lifestyle

More information

Hypertension Best Practices Symposium

Hypertension Best Practices Symposium essentia health: east region 1 Hypertension Best Practices Symposium RN Hypertension Management Pilot Essentia Health: East Region Duluth, MN ORGANIZATION PROFILE Essentia Health is an integrated health

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Tackling the Semantic Interoperability challenge

Tackling the Semantic Interoperability challenge European Patient Summaries: What is next? Tackling the Semantic Interoperability challenge Dipak Kalra Cross-border health care The context for sharing health summaries Also useful for within-border health

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

High Blood pressure and chronic kidney disease

High Blood pressure and chronic kidney disease High Blood pressure and chronic kidney disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information

Chronic Disease and Health Care Spending Among the Elderly

Chronic Disease and Health Care Spending Among the Elderly Chronic Disease and Health Care Spending Among the Elderly Jay Bhattacharya, MD, PhD for Dana Goldman and the RAND group on medical care expenditure forecasting Chronic Disease Plays an Increasingly Important

More information

An Introduction to Medication Adherence

An Introduction to Medication Adherence An Introduction to Medication Adherence Medication Adherence Project (MAP) A project of the Cardiovascular Prevention & Control Program and the Fund for Public Health in New York Drugs don t work in patients

More information

MY TYPE 2 DIABETES NUMBERS

MY TYPE 2 DIABETES NUMBERS BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,

More information

High Blood Pressure and Chronic Kidney Disease

High Blood Pressure and Chronic Kidney Disease High Blood Pressure and Chronic Kidney Disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information

IDB Jointly surveilling diseases in the Caribbean

IDB Jointly surveilling diseases in the Caribbean IDB Jointly surveilling diseases in the Caribbean Organization(s): Ministries of Health of The Bahamas, Barbados, Belize, Guyana, Jamaica and Trinidad and Tobago. The strategic partners accompanying the

More information

Against the Growing Burden of Disease. Kimberly Elmslie Director General, Centre for Chronic Disease Prevention

Against the Growing Burden of Disease. Kimberly Elmslie Director General, Centre for Chronic Disease Prevention Kimberly Elmslie Director General, Centre for Chronic Disease Prevention Chronic diseases are an increasing global challenge Most significant cause of death (63%) worldwide 1 Chronic diseases cause premature

More information

How To Control Hypertension In Finnish Karelia

How To Control Hypertension In Finnish Karelia Antihypertensive Drug Treatment in a id die-aged Population HANNES ENLUND,.PHAR., AULIKKI NISSINEN,.D., N.T., PH.D., AND JAAKKO TUOILEHTO,.D., PH.D. SUARY In Finland's region a community-based program

More information

Remote Monitoring. Remote Monitoring. Project 21: The Cell-Life Project. Credit: Mobiles in Malawi/Josh Nesbit. 50 Compendium of mhealth Projects

Remote Monitoring. Remote Monitoring. Project 21: The Cell-Life Project. Credit: Mobiles in Malawi/Josh Nesbit. 50 Compendium of mhealth Projects Remote Monitoring Project 21: The Cell-Life Project Country: South Africa Sponsoring Organization and Partners: The University of Cape Town, the Cape Peninsula University of Technology and Cell-Life Providing

More information

R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney,

R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney, R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney, Australia Cardiac rehabilitation is an effective and safe

More information

Report on comparing quality among Medicare Advantage plans and between Medicare Advantage and fee-for-service Medicare

Report on comparing quality among Medicare Advantage plans and between Medicare Advantage and fee-for-service Medicare O N L I N E A P P E N D I X E S 6 Report on comparing quality among Medicare Advantage plans and between Medicare Advantage and fee-for-service Medicare 6-A O N L I N E A P P E N D I X Current quality

More information

InDependent Diabetes Trust

InDependent Diabetes Trust InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use

More information

Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims

Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims Guidance for Industry Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research

More information

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost

Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Aggressive Lowering of Blood Pressure in type 2 Diabetes Mellitus: The Diastolic Cost Naftali Stern Institute of Endocrinology, Metabolism and Hypertension Tel Aviv -Sourasky Medical Center and Sackler

More information

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis

Psoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic

More information

Basic of Epidemiology in Ophthalmology Rajiv Khandekar. Presented in the 2nd Series of the MEACO Live Scientific Lectures 11 August 2014 Riyadh, KSA

Basic of Epidemiology in Ophthalmology Rajiv Khandekar. Presented in the 2nd Series of the MEACO Live Scientific Lectures 11 August 2014 Riyadh, KSA Basic of Epidemiology in Ophthalmology Rajiv Khandekar Presented in the 2nd Series of the MEACO Live Scientific Lectures 11 August 2014 Riyadh, KSA Basics of Epidemiology in Ophthalmology Dr Rajiv Khandekar

More information

Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group.

Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group. Int J Diabetes & Metabolism (2007) 15: 82-86 Control of hypertension in Nigerians with Diabetes Mellitus: A report of the Ibadan Diabetic / Kidney Disease Study Group. Ayodeji Arije, 1 Modupe Kuti, 2 Adesoji

More information

Non-response bias in a lifestyle survey

Non-response bias in a lifestyle survey Journal of Public Health Medicine Vol. 19, No. 2, pp. 203-207 Printed in Great Britain Non-response bias in a lifestyle survey Anthony Hill, Julian Roberts, Paul Ewings and David Gunnell Summary Background

More information

Albumin and All-Cause Mortality Risk in Insurance Applicants

Albumin and All-Cause Mortality Risk in Insurance Applicants Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH

More information

THE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY

THE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY Analele UniversităŃii din Oradea Fascicula:Ecotoxicologie, Zootehnie şi Tehnologii de Industrie Alimentară, 2012 THE STUDY OF NEWLY DISCOVERED CASES OF DIABETES MELLITUS IN BIHOR COUNTY *University of

More information

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT

PROCEEDINGS DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT DIABETIC NEPHROPATHY: DETECTION AND TREATMENT OF RENAL DISEASE IN PATIENTS WITH DIABETES* Jiten Vora, MA, MD, FRCP ABSTRACT Diabetic nephropathy affects people with either type 1 or type 2 diabetes mellitus.

More information

Part 4 Burden of disease: DALYs

Part 4 Burden of disease: DALYs Part Burden of disease:. Broad cause composition 0 5. The age distribution of burden of disease 6. Leading causes of burden of disease 7. The disease and injury burden for women 6 8. The growing burden

More information

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D. TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type

More information

Elevated Blood Pressure Among U.S. Adults with Diabetes, 1988 1994

Elevated Blood Pressure Among U.S. Adults with Diabetes, 1988 1994 Elevated Blood Pressure Among U.S. Adults with Diabetes, 1988 1994 Linda S. Geiss, MA, Deborah B. Rolka, MS, Michael M. Engelgau, MD, MS Background: Methods: Results: Conclusions: Recent guidelines and

More information

NCDs POLICY BRIEF - INDIA

NCDs POLICY BRIEF - INDIA Age group Age group NCDs POLICY BRIEF - INDIA February 2011 The World Bank, South Asia Human Development, Health Nutrition, and Population NON-COMMUNICABLE DISEASES (NCDS) 1 INDIA S NEXT MAJOR HEALTH CHALLENGE

More information

Do nurse practitioners working in primary care provide equivalent care to doctors?

Do nurse practitioners working in primary care provide equivalent care to doctors? August 2008 SUPPORT Summary of a systematic review Do nurse practitioners working in primary care provide equivalent care to doctors? Nurse practitioners are nurses who have undergone further training,

More information

Do general practitioners prescribe more antimicrobials when the weekend comes?

Do general practitioners prescribe more antimicrobials when the weekend comes? DOI 10.1186/s40064-015-1505-6 RESEARCH Open Access Do general practitioners prescribe more antimicrobials when the weekend comes? Meera Tandan 1*, Sinead Duane 1 and Akke Vellinga 1,2 Abstract Inappropriate

More information

Tim A. Holt PhD, Candace L. Gunnarsson EdD, Paul A. Cload PhD, Susan D. Ross MD

Tim A. Holt PhD, Candace L. Gunnarsson EdD, Paul A. Cload PhD, Susan D. Ross MD Identification of undiagnosed diabetes and quality of diabetes care in the United States: cross-sectional study of 11.5 million primary care electronic records Tim A. Holt PhD, Candace L. Gunnarsson EdD,

More information

HEALTH RISK ASSESSMENT (HRS) QUESTIONNAIRE

HEALTH RISK ASSESSMENT (HRS) QUESTIONNAIRE HEALTH RISK ASSESSMENT (HRS) QUESTIONNAIRE The Health Risk Assessment (HRA) questionnaire provides participants with an evaluation of their current health and quality of life. The assessment promotes health

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

OEM MAXNIBP Frequently Asked Questions

OEM MAXNIBP Frequently Asked Questions Frequently Asked Questions Why does the monitor sometimes inflate the BP cuff, then shortly thereafter reinflate the cuff? How will I know if the monitor is experiencing motion artifact during a measurement?

More information

After acute myocardial infarction, diabetes CARDIAC OUTCOMES AFTER MYOCARDIAL INFARCTION IN ELDERLY PATIENTS WITH DIABETES MELLITUS

After acute myocardial infarction, diabetes CARDIAC OUTCOMES AFTER MYOCARDIAL INFARCTION IN ELDERLY PATIENTS WITH DIABETES MELLITUS CARDIAC OUTCOMES AFTER MYOCARDIAL INFARCTION IN ELDERLY PATIENTS WITH DIABETES MELLITUS By Deborah Chyun, RN, PhD, Viola Vaccarino, MD, PhD, Jaime Murillo, MD, Lawrence H. Young, MD, and Harlan M. Krumholz,

More information

Racial and Ethnic Disparities in Maternal Mortality in the United States

Racial and Ethnic Disparities in Maternal Mortality in the United States Racial and Ethnic Disparities in Maternal Mortality in the United States KYRIAKOS S. MARKIDES, PHD UNIVERSITY OF TEXAS MEDICAL BRANCH GALVESTON, TEXAS PRESENTED AT THE HOWARD TAYLOR INTERNATIONAL SYMPOSIUM

More information

Combination Antihypertensive Therapy: When to use it Diabetes

Combination Antihypertensive Therapy: When to use it Diabetes Combination Antihypertensive Therapy: When to use it Diabetes George L. Bakris, MD, F.A.S.N., F.A.S.H. Professor of Medicine Director, ASH Comprehensive Hypertension Center The University of Chicago Medicine

More information

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18

More information

Shutterstock TACstock

Shutterstock TACstock Shutterstock TACstock 10 Introduction Since 2000, the IDF Diabetes Atlas has detailed the extent of diabetes and this seventh edition shows how it is impacting every country, every age group and every

More information

Vascular Risk Reduction: Addressing Vascular Risk

Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction: Addressing Vascular Risk Vascular Risk Reduction (VRR) Welcome! Presentation & Activities Focus: Managing known risk factors for vascular disease. Engage, collaborate and have

More information

The population with diabetes is less healthy than the population without it.

The population with diabetes is less healthy than the population without it. Diabetes A drain on U.S. resources Some people with diabetes are able to control their condition and lead an active life. On the whole, however, people with diabetes are faced with many challenges. The

More information

What are the PH interventions the NHS should adopt?

What are the PH interventions the NHS should adopt? What are the PH interventions the NHS should adopt? South West Clinical Senate 15 th January, 2015 Debbie Stark, PHE Healthcare Public Health Consultant Kevin Elliston: PHE Consultant in Health Improvement

More information

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes

Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center

More information

Work-site hypertension prevalence and control in three Central European Countries

Work-site hypertension prevalence and control in three Central European Countries (2004) 18, 581 585 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Work-site hypertension prevalence and control in three Central European Countries

More information